Skip to main content
Erschienen in: Obesity Surgery 11/2018

05.09.2018 | Review Article

Whether a Short or Long Alimentary Limb Influences Weight Loss in Gastric Bypass: a Systematic Review and Meta-Analysis

verfasst von: Jiadi Gan, Yingjin Wang, Xiaodong Zhou

Erschienen in: Obesity Surgery | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Roux-en-Y gastric bypass, the most commonly performed procedure in bariatric surgery, still lacks a consensus on whether alimentary limb length (ALL) influences weight loss. Studies were identified by searching multiple electronic databases. Studies with enough data including body mass index (BMI) loss and percent excess weight loss (% EWL) were eligible. The statistical analysis was performed with Stata 14.0. In total, eight studies with 1714 patients were included. The meta-analysis suggested that short ALLs weakened the efficacy of Roux-en-Y gastric bypass in terms of BMI loss (standard mean deviation (SMD), − 0.33 [95% confidence intervals (CI), − 0.60, − 0.05], p = 0.021) with 3 years of follow-up and % EWL (SMD, − 0.17 [95% CI, − 0.31, − 0.04], p = 0.013) with 2 years of follow-up. The subgroup analysis demonstrated that the group with a BMI ≥ 50 kg/m2 had a significant SMD between the use of short and the standard ALLs (− 0.71 [95% CI, − 1.07, − 0.35], p = 0.000), while the subgroup with a BMI < 50 kg/m2 (SMD, − 0.29 [95% CI, − 0.78, 0.20], p = 0.247) did not. Compared with a standard ALL (130–150 cm), a short ALL (40–100 cm) may reduce the efficacy of the Roux-en-Y gastric bypass surgery, while a long ALL (170–250 cm) did not significantly improve the effects in terms of BMI loss and % EWL. In addition, a potential view of the meta-analysis indicated patients with a BMI < 50 kg/m2 might get more benefits with a short ALL, while those patients with a BMI ≥ 50 kg/m2 might benefit more from a standard ALL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat World Health Organization. Obesity and overweight. New York: Springer; 2013. p. 1913–5. World Health Organization. Obesity and overweight. New York: Springer; 2013. p. 1913–5.
2.
Zurück zum Zitat Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. Nchs Data Brief. 2015;(219):1–8. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. Nchs Data Brief. 2015;(219):1–8.
3.
Zurück zum Zitat Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219–30.CrossRefPubMed Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219–30.CrossRefPubMed
4.
Zurück zum Zitat Yoon PW, Bastian B, Anderson RN, et al. Potentially preventable deaths from the five leading causes of death—United States, 2008–2010. Mmwr Morb Mortal Wkly Rep. 2014;63(17):369–74.PubMedPubMedCentral Yoon PW, Bastian B, Anderson RN, et al. Potentially preventable deaths from the five leading causes of death—United States, 2008–2010. Mmwr Morb Mortal Wkly Rep. 2014;63(17):369–74.PubMedPubMedCentral
5.
Zurück zum Zitat Brunaldi VO, Jirapinyo P, Moura DTHD, et al. Endoscopic treatment of weight regain following Roux-en-Y gastric bypass: a systematic review and meta-analysis. Obes Surg. 2018;28(1):266–76.CrossRefPubMed Brunaldi VO, Jirapinyo P, Moura DTHD, et al. Endoscopic treatment of weight regain following Roux-en-Y gastric bypass: a systematic review and meta-analysis. Obes Surg. 2018;28(1):266–76.CrossRefPubMed
6.
Zurück zum Zitat Dempsey DT. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.CrossRef Dempsey DT. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.CrossRef
7.
Zurück zum Zitat Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.CrossRefPubMed Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.CrossRefPubMed
8.
Zurück zum Zitat Jr FA, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239(5):702–3. Jr FA, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239(5):702–3.
9.
Zurück zum Zitat Consortium LAOBS, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.CrossRef Consortium LAOBS, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.CrossRef
10.
Zurück zum Zitat Pinheiro JS, Schiavon CA, Pereira PB, et al. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis. 2008;4(4):521.CrossRefPubMed Pinheiro JS, Schiavon CA, Pereira PB, et al. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis. 2008;4(4):521.CrossRefPubMed
11.
Zurück zum Zitat O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol. 2010;25(8):1358.CrossRefPubMed O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol. 2010;25(8):1358.CrossRefPubMed
12.
Zurück zum Zitat Buchwald H, Buchwald JN. Evolution of operative procedures for the management of morbid obesity 1950–2000. Obes Surg. 2002;12(5):705–17.CrossRefPubMed Buchwald H, Buchwald JN. Evolution of operative procedures for the management of morbid obesity 1950–2000. Obes Surg. 2002;12(5):705–17.CrossRefPubMed
13.
Zurück zum Zitat Pories WJ, Swanson MS, Macdonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50.CrossRefPubMedPubMedCentral Pories WJ, Swanson MS, Macdonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Madan AK, Harper JL, Tichansky DS. Techniques of laparoscopic gastric bypass: on-line survey of American Society for Bariatric Surgery practicing surgeons. Surg Obes Relat Dis. 2008;4(2):166–72.CrossRefPubMed Madan AK, Harper JL, Tichansky DS. Techniques of laparoscopic gastric bypass: on-line survey of American Society for Bariatric Surgery practicing surgeons. Surg Obes Relat Dis. 2008;4(2):166–72.CrossRefPubMed
15.
Zurück zum Zitat Feng JJ, Gagner M, Pomp A, Korgaonkar NM, Jacob BP, Chu CA, et al. Effect of standard vs extended Roux limb length on weight loss outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2003;17(7):1055-60.CrossRefPubMed Feng JJ, Gagner M, Pomp A, Korgaonkar NM, Jacob BP, Chu CA, et al. Effect of standard vs extended Roux limb length on weight loss outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2003;17(7):1055-60.CrossRefPubMed
16.
Zurück zum Zitat Freeman JB, Kotlarewsky M, Phoenix C. Weight loss after extended gastric bypass. Obes Surg. 1997;7(4):337–44.CrossRefPubMed Freeman JB, Kotlarewsky M, Phoenix C. Weight loss after extended gastric bypass. Obes Surg. 1997;7(4):337–44.CrossRefPubMed
17.
Zurück zum Zitat Risstad H, Svanevik M, Kristinsson JA, Hjelmesæth J, Aasheim ET, Hofsø D, et al. Standard vs distal Roux-en-Y gastric bypass in patients with body mass index 50 to 60: a double-blind, randomized clinical trial. Jama Surg. 2016;151(12):1146-1155.CrossRefPubMed Risstad H, Svanevik M, Kristinsson JA, Hjelmesæth J, Aasheim ET, Hofsø D, et al. Standard vs distal Roux-en-Y gastric bypass in patients with body mass index 50 to 60: a double-blind, randomized clinical trial. Jama Surg. 2016;151(12):1146-1155.CrossRefPubMed
18.
19.
Zurück zum Zitat Sarhan M, Choi JJ, Sawwaf MA, et al. Is weight loss better sustained with long-limb gastric bypass in the super-obese? Obes Surg. 2011;21(9):1337–43.CrossRefPubMed Sarhan M, Choi JJ, Sawwaf MA, et al. Is weight loss better sustained with long-limb gastric bypass in the super-obese? Obes Surg. 2011;21(9):1337–43.CrossRefPubMed
20.
Zurück zum Zitat Gleysteen JJ. Five-year outcome with gastric bypass: Roux limb length makes a difference. Surg Obes Relat Dis. 2009;5(2):242–7.CrossRefPubMed Gleysteen JJ. Five-year outcome with gastric bypass: Roux limb length makes a difference. Surg Obes Relat Dis. 2009;5(2):242–7.CrossRefPubMed
21.
Zurück zum Zitat Inabnet WB, Quinn T, Gagner M, et al. Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg. 2005;15(1):51.CrossRefPubMed Inabnet WB, Quinn T, Gagner M, et al. Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg. 2005;15(1):51.CrossRefPubMed
22.
Zurück zum Zitat Flancbaum L, Verducci JS, Choban PS. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity are not related to bypass limb-length. Obes Surg. 1998;8(4):437–43.CrossRefPubMed Flancbaum L, Verducci JS, Choban PS. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity are not related to bypass limb-length. Obes Surg. 1998;8(4):437–43.CrossRefPubMed
23.
Zurück zum Zitat Cable CT, Colbert CY, Showalter T, et al. Prevalence of anemia after Roux-en-Y gastric bypass surgery: what is the right number? Surg Obes Relat Dis. 2011;7(2):134–9.CrossRefPubMed Cable CT, Colbert CY, Showalter T, et al. Prevalence of anemia after Roux-en-Y gastric bypass surgery: what is the right number? Surg Obes Relat Dis. 2011;7(2):134–9.CrossRefPubMed
24.
Zurück zum Zitat Dallal RM, Leighton J, Trang A. Analysis of leukopenia and anemia after gastric bypass surgery. Surg Obes Relat Dis. 2012;8(2):164–8.CrossRefPubMed Dallal RM, Leighton J, Trang A. Analysis of leukopenia and anemia after gastric bypass surgery. Surg Obes Relat Dis. 2012;8(2):164–8.CrossRefPubMed
25.
Zurück zum Zitat Wells GA, Shea BJ, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2012;18(6):727–34. Wells GA, Shea BJ, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2012;18(6):727–34.
26.
Zurück zum Zitat Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.CrossRef Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.CrossRef
27.
Zurück zum Zitat Higgins JPT, Thompson SG. Quantifying heterogeneity in meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRef Higgins JPT, Thompson SG. Quantifying heterogeneity in meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRef
28.
Zurück zum Zitat Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Hoboken: Wiley-Blackwell; 2008. p. 285–312. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Hoboken: Wiley-Blackwell; 2008. p. 285–312.
29.
30.
Zurück zum Zitat Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455.CrossRefPubMed Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455.CrossRefPubMed
31.
Zurück zum Zitat Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis: prevention, assessment and adjustments. Psychometrika. 2007;72(2):269.CrossRef Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis: prevention, assessment and adjustments. Psychometrika. 2007;72(2):269.CrossRef
32.
Zurück zum Zitat Dogan K, Homan J, Aarts EO, et al. A short or a long Roux limb in gastric bypass surgery: does it matter? Surg Endosc. 2016;31(4):1–9. Dogan K, Homan J, Aarts EO, et al. A short or a long Roux limb in gastric bypass surgery: does it matter? Surg Endosc. 2016;31(4):1–9.
33.
Zurück zum Zitat Ciovica R, Takata M, Vittinghoff E, et al. The impact of roux limb length on weight loss after gastric bypass. Obes Surg. 2008;18(1):5–10.CrossRefPubMed Ciovica R, Takata M, Vittinghoff E, et al. The impact of roux limb length on weight loss after gastric bypass. Obes Surg. 2008;18(1):5–10.CrossRefPubMed
34.
Zurück zum Zitat Moizé V, Andreu A, Flores L, et al. Long-term dietary intake and nutritional deficiencies following sleeve gastrectomy or Roux-En-Y gastric bypass in a Mediterranean population. J Acad Nutr Diet. 2013;113(3):400–10.CrossRefPubMed Moizé V, Andreu A, Flores L, et al. Long-term dietary intake and nutritional deficiencies following sleeve gastrectomy or Roux-En-Y gastric bypass in a Mediterranean population. J Acad Nutr Diet. 2013;113(3):400–10.CrossRefPubMed
35.
Zurück zum Zitat Obinwanne KM, Fredrickson KA, Mathiason MA, et al. Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis. J Am Coll Surg. 2014;218(2):246–52.CrossRefPubMed Obinwanne KM, Fredrickson KA, Mathiason MA, et al. Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis. J Am Coll Surg. 2014;218(2):246–52.CrossRefPubMed
36.
Zurück zum Zitat Kofman MD, Lent MR, Swencionis C. Maladaptive eating patterns, quality of life, and weight outcomes following gastric bypass: results of an Internet survey. Obesity. 2010;18(10):1938–43.CrossRefPubMed Kofman MD, Lent MR, Swencionis C. Maladaptive eating patterns, quality of life, and weight outcomes following gastric bypass: results of an Internet survey. Obesity. 2010;18(10):1938–43.CrossRefPubMed
37.
Zurück zum Zitat Thompson CC, Jacobsen GR, Schroder GL, et al. Stoma size is critical to twelve month outcomes in endoscopic suturing for gastric bypass repair. Surg Obes Relat Dis. 2012;8(3):282–7.CrossRefPubMed Thompson CC, Jacobsen GR, Schroder GL, et al. Stoma size is critical to twelve month outcomes in endoscopic suturing for gastric bypass repair. Surg Obes Relat Dis. 2012;8(3):282–7.CrossRefPubMed
38.
Zurück zum Zitat Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.CrossRefPubMedPubMedCentral Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Liu Y, Guo W, Zhang J, et al. Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis. Am J Kidney Dis. 2013;62(6):1058–67.CrossRefPubMed Liu Y, Guo W, Zhang J, et al. Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis. Am J Kidney Dis. 2013;62(6):1058–67.CrossRefPubMed
40.
Zurück zum Zitat Li ZZ, Xue J, Chen P, et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014;29(1):42–51.CrossRefPubMed Li ZZ, Xue J, Chen P, et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014;29(1):42–51.CrossRefPubMed
41.
Zurück zum Zitat Torres J, Why I. Prefer gastric bypass distal Roux-en-Y gastroileostomy. Obes Surg. 1991;1(2):189–94.CrossRefPubMed Torres J, Why I. Prefer gastric bypass distal Roux-en-Y gastroileostomy. Obes Surg. 1991;1(2):189–94.CrossRefPubMed
42.
Zurück zum Zitat Torres J. Gastric bypass distal Roux-en-Y with jejunal interposition. Obes Surg. 1993;3(2):191–5.CrossRefPubMed Torres J. Gastric bypass distal Roux-en-Y with jejunal interposition. Obes Surg. 1993;3(2):191–5.CrossRefPubMed
43.
Zurück zum Zitat Torres J. Gastric bypass distal Roux-en-Y jejunal interposition with selective proximal vagotomy and posterior truncal vagotomy. Obes Surg. 1994;4(3):279–84.CrossRefPubMed Torres J. Gastric bypass distal Roux-en-Y jejunal interposition with selective proximal vagotomy and posterior truncal vagotomy. Obes Surg. 1994;4(3):279–84.CrossRefPubMed
Metadaten
Titel
Whether a Short or Long Alimentary Limb Influences Weight Loss in Gastric Bypass: a Systematic Review and Meta-Analysis
verfasst von
Jiadi Gan
Yingjin Wang
Xiaodong Zhou
Publikationsdatum
05.09.2018
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2018
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3475-6

Weitere Artikel der Ausgabe 11/2018

Obesity Surgery 11/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.